Biotech
SAN DIEGO, CA: Company Scientist Notes That One of the Major Side Effects Is the Destruction of Blood Vessels Leading to Internal Bleeding Which May Be Mitigated by Immunotherapeutic "Cocktail" ...
BUFFALO, NY: BUFFALO, NY -- (Marketwired) -- 10/28/14 -- (NASDAQ: CBLI) today announced that on November 5, 2014, it will report its financial results for the third quarter ended September 30, 2014, and will host ...
NORWOOD, MA: NORWOOD, MA -- (Marketwired) -- 10/28/14 -- (OTCQB: CRBP), an emerging drug development company focused on the development and commercialization of its lead product candidate, ™, for the treatment ...
ROCKVILLE, MARYLAND and LAVAL, QUEBEC: - Enrollment of Phase I patients to start in Q4 2014 - Agreement for the proposed Phase II/III clinical program to follow an accelerated approval pathway - First PPPS(TM) generated plasma-derived ther ...
LAVAL, QUEBEC: LAVAL, QUEBEC -- (Marketwired) -- 10/27/14 -- ProMetic Life Sciences Inc. (TSX: PLI)(OTCQX: PFSCF) ("ProMetic" or the "Corporation") today announced that it will be holding a pla ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 10/27/14 -- CompareNetworks, Inc., a leading provider of media and platform products in web and mobile formats for the scientific and healthcare industries ...
BRISBANE, AUSTRALIA: BRISBANE, AUSTRALIA -- (Marketwired) -- 10/26/14 -- Alchemia Limited (ASX: ACL)Phase III trial does not reach primary endpoint of statistically significant improvement in progression-free survivalAlc ...
EDMONTON, ALBERTA: EDMONTON, ALBERTA -- (Marketwired) -- 10/24/14 -- The Alberta Prion Research Institute is partnering with Lakeland College and Medicine Hat College to host free public lectures featuring Jay Ingram, ...
NEWCASTLE UPON TYNE, UNITED KINGDOM: NEWCASTLE UPON TYNE, UNITED KINGDOM -- (Marketwired) -- 10/24/14 --,- A next generation linker displaying very high stability with improved selectivity and specificity -
- Efficacy outperformed that o ...
LONDON, ONTARIO: LONDON, ONTARIO -- (Marketwired) -- 10/23/14 -- Critical Outcome Technologies Inc. (COTI) (TSX VENTURE: COT)(OTCQB: COTQF), the biopharmaceutical company that uses machine learning to rapidly develo ...
SAN FRANCISCO, CA and YAVNE, ISRAEL: SAN FRANCISCO, CA and YAVNE, ISRAEL -- (Marketwired) -- 10/23/14 -- Medivation, Inc. (NASDAQ: MDVN) and CureTech, Ltd. today announced Medivation has licensed exclusive worldwide rights to CureTech&# ...
SAN FRANCISCO, CA: SAN FRANCISCO, CA -- (Marketwired) -- 10/23/14 -- Medivation, Inc. (NASDAQ: MDVN) today announced that it will host a live teleconference with management to discuss third quarter 2014 financial resul ...
BEVERLY, MA: BEVERLY, MA -- (Marketwired) -- 10/23/14 -- Cellceutix Corporation (OTCQB: CTIX) (the "Company"), a clinical stage biopharmaceutical company developing innovative therapies in oncology, der ...
LONDON, ONTARIO: Focus on the clinical development of lead compound, COTI-2, continues ...
COLUMBIA, MD and TORONTO, ON: Poster Presentation Outlining the Pivotal Phase III Clinical Study Currently Being Investigated at VM Medical, the Largest Non Public Private Breast Center in Canada ...
EXTON, PA: EXTON, PA -- (Marketwired) -- 10/23/14 -- West Pharmaceutical Services, Inc. (NYSE: WST) today that it will release third quarter 2014 financial results before the market opens on Thursday, October 3 ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 10/23/14 -- InMed Pharmaceuticals Inc. ("InMed") (CSE: IN)(OTCQB: IMLFF) announces it has has formed an exclusive strategic collaboration wit ...
SEATTLE, WA: SEATTLE, WA -- (Marketwired) -- 10/22/14 -- Atossa Genetics Inc. (NASDAQ: ATOS) today announced it has received certification to Annex II of the European Medical Device Directive (MDD) from its Europ ...
DUBLIN, IRELAND: DUBLIN, IRELAND -- (Marketwired) -- 10/21/14 -- Horizon Pharma plc (NASDAQ: HZNP) announced today that its third quarter 2014 financial results will be released on Thursday, November 6, 2014. Followi ...
WINSTON-SALEM, NC and PHILADELPHIA, PA: Dell Recognizes Clinical Ink as High-Growth Startup Poised for Significant Growth Based on Record of Disrupting Life Sciences With Innovative Technology ...
